Brief: Aptose Announces Proposed Public Offering Of Common Shares
16/12/2019 22:09
Dec 16 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
* APTOSE BIOSCIENCES - INTENDS TO USE ALL OR PORTION OF NET
PROCEEDS TO ACCELERATE AND EXPAND CLINICAL TRIALS FOR CG-806
* APTOSE BIOSCIENCES - ALSO INTENDS TO USE ALL OR PORTION OF
NET
PROCEEDS TO ACCELERATE AND EXPAND CLINICAL TRIALS FOR APTO-253,
AMONG OTHERS
Source text for Eikon: ID:nGNXbwxgNH
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting